| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 10/01/2008 | CN100422155C Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same |
| 10/01/2008 | CN100421721C Medication for relieving cough and asthma |
| 10/01/2008 | CN100421677C Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn. |
| 10/01/2008 | CN100421676C Lactic acid producing bacteria and lung function |
| 10/01/2008 | CN100421669C A low-sugar granule for treating infants cold and preparation method thereof |
| 10/01/2008 | CN100421655C Pharmaceutical composition for stabilizing ambroxol hydrochloride granula |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429591 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(2-Amino-6-chloro-phenyl)-piperazin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 09/30/2008 | US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 09/30/2008 | US7429586 Non-imidazole aryloxyalkylamines |
| 09/30/2008 | US7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use |
| 09/30/2008 | US7429488 Method for processing lipoaspirate cells |
| 09/30/2008 | US7429471 regulation of matrix metalloproteinase gene expression in cartilage cells via the application of fields generated by specific and selective electric and electromagnetic signals in the treatment of diseased or injured articular cartilage. By gene expression is meant the up-regulation or down-regulation |
| 09/30/2008 | CA2626514A1 Sinus relief composition and method of producing the same |
| 09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
| 09/30/2008 | CA2338220C Substituted imidazoles having cytokine inhibitory activity |
| 09/30/2008 | CA2303848C Substituted anilides |
| 09/30/2008 | CA2183050C Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 09/25/2008 | WO2008115141A1 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders |
| 09/25/2008 | WO2008115140A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114812A1 Jak inhibitor |
| 09/25/2008 | WO2008114280A1 Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
| 09/25/2008 | WO2008113965A1 Indolizine acetic acid derivatives as crth2 antagonists |
| 09/25/2008 | WO2008113500A1 Methods and compounds for modulating inflammatory processes |
| 09/25/2008 | WO2008113183A1 Use of francisella tularensis for prevention and treatment of allergic airway disorders |
| 09/25/2008 | WO2008084319A3 Novel nucleic acid |
| 09/25/2008 | WO2008027585A3 Pyrrolo[3,2-d]pyrimidines that are selective antagonists of a2b adenosine receptors |
| 09/25/2008 | WO2008002449A3 Glycomimetic inhibitors of siglec-8 |
| 09/25/2008 | US20080234376 Prostaglandin E1, a phospholipid with a high purity and a non-proton-providing surfactant; hypertension, thrombosis, asthma, gastric and intestinal ulcers |
| 09/25/2008 | US20080234362 Treatment for Asthma and Arthritis and Other Inflammatory Diseases |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234325 Novel Methods Using Pyridine Derivatives |
| 09/25/2008 | US20080234316 Quinuclidine Amide Derivatives |
| 09/25/2008 | US20080234283 Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseases |
| 09/25/2008 | US20080234259 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse, vision defect, neurodegenerative diseases; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; antiinflammatory agent, antidepressant |
| 09/25/2008 | US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
| 09/25/2008 | US20080234189 Treatment of inflammation related to an autoimmune disease, such as asthma, arthritis, psoriasis, or inflammatory bowel disease by adminstering an extracellular adherence protein; recruitment of leukocytes or neutrophils to an inflammation site is prevented |
| 09/25/2008 | US20080233194 Stabilized ; dispersion in dispersion microstructure; administering to lungs |
| 09/25/2008 | US20080233188 [5-(4-bromo-phenyl)-6-[2-(5-bromo-pyrimidin-2-yloxy)-ethoxy]-pyrimidin-4-yl]-amide, a disintegrant, a surfactant, and a lubricant; endothelin receptor inhibitor |
| 09/25/2008 | US20080233185 Using dimethyl fumarate and/or diethyl fumarate, calcium alkyl fumarate, calcium methyl fumarate and/or calcium ethyl fumarate, zinc methyl fumarate and/or zinc ethyl fumarate, methyl hydrogen fumarate and/or ethyl hydrogen fumarate; sclerodermia, osteochondritis syphilitica (Wegener's disease) |
| 09/25/2008 | US20080233163 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease |
| 09/25/2008 | US20080233119 Modulating death receptor 3 and/or CD30 function; interleukin expression inhibition |
| 09/25/2008 | US20080233113 Cardiovascular conditions, ischemia-reperfusion injury, atherosclerosis, inflammatory gastrointestinal disorder, pulmonary condition, musculoskeletal conditions, renal conditions, skin conditions, organ or tissue transplants, nervous system disorders |
| 09/25/2008 | US20080233103 Mycobacterial peptide deformylase |
| 09/25/2008 | CA2681466A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |
| 09/25/2008 | CA2681409A1 Indolizine acetic acid derivatives as crth2 antagonists |
| 09/25/2008 | CA2680397A1 Novel adenine compound |
| 09/25/2008 | CA2679686A1 Use of francisella tularensis for prevention and treatment of allergic airway disorders |
| 09/25/2008 | CA2677733A1 Conjugates of synthetic tlr agonists and uses therefor |
| 09/24/2008 | EP1972626A2 Process for producing scopine esters |
| 09/24/2008 | EP1971572A1 Cyclic amine derivatives and their uses |
| 09/24/2008 | EP1971369A2 Combination of anticholinergics, glucocorticoids, beta2-agonists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
| 09/24/2008 | EP1971332A1 Use of tiotropium salts in the treatment of moderate persistent asthma |
| 09/24/2008 | EP1537096B1 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | EP1509528B1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/24/2008 | EP1438031B1 Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 09/24/2008 | EP1411128B1 Recombinant viral vectors containing the human urokinase plasminogen activator gene and their utilization in the treatment of hepatic fibrosis |
| 09/24/2008 | CN101273013A Sulfonamide derivative having PGD2 receptor antagonistic activity |
| 09/24/2008 | CN101269168A Traditional Chinese medicine for treating cough and asthma of children |
| 09/24/2008 | CN101269159A Chinese medicinal composition for treating upper sinus frontalis cancer and preparation method thereof |
| 09/24/2008 | CN101269143A Method for preparing Fupoganmao particle and prepared product |
| 09/24/2008 | CN101269117A Compound Senecio Cannabifolius Less composition for preventing and treating laryngopharyngitis |
| 09/24/2008 | CN101269116A Chaihuang soft capsule and quality control method |
| 09/24/2008 | CN101269097A Alstonia-leaf medicinal materials and medicament testing method for its preparation |
| 09/24/2008 | CN101269092A Snake venom cytotoxin, preparation method and application thereof |
| 09/24/2008 | CN101269085A Oral preparation containing azithromycin, preparation method and application thereof |
| 09/24/2008 | CN101269083A Oral preparation containing mydecamycin, preparation method and application thereof |
| 09/24/2008 | CN101269079A Emulsion composition comprising prostaglandin E1 |
| 09/24/2008 | CN101269075A Medicament composition containing ambroxol and benproperine, and uses thereof |
| 09/24/2008 | CN101269071A Oral preparation containing amoxicillin and flucloxacillin, preparation method and application thereof |
| 09/24/2008 | CN101269070A Oral preparation containing amoxicillin, preparation method and application thereof |
| 09/24/2008 | CN101269069A Oral preparation containing amoxicillin and clavulanic acid, preparation method and application thereof |
| 09/24/2008 | CN101269068A Oral preparation containing penicillin V kalium, preparation method and application thereof |
| 09/24/2008 | CN101269055A Ambroxol hydrochloride oral cavity disintegrating tablet and method of producing the same |
| 09/24/2008 | CN101269038A Chlorpheniramine maleate sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269034A Nimesulide sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269033A Ambroxol hydrochloride sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269006A Oral preparation containing ampicillin, preparation method and application thereof |
| 09/24/2008 | CN101269005A Oral preparation containing erythromycin, preparation method and application thereof |
| 09/24/2008 | CN101269004A Oral preparation containing clarithromycin, preparation method and application thereof |
| 09/24/2008 | CN101269003A Oral preparation containing roxithromycin, preparation method and application thereof |
| 09/24/2008 | CN101269002A Oral preparation containing penicillin G, preparation method and application thereof |
| 09/24/2008 | CN101269001A Oral preparation containing gentamicin, preparation method and application thereof |
| 09/24/2008 | CN101269000A Oral preparation containing cefa-iskia, preparation method and application thereof |
| 09/24/2008 | CN101268999A Oral preparation containing cefaclor, preparation method and application thereof |
| 09/24/2008 | CN101268794A Complex of tea bamboo juice and application thereof |
| 09/24/2008 | CN100420689C Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant |
| 09/24/2008 | CN100420682C Separating preparation process of salvianolic acid B |
| 09/24/2008 | CN100420482C Method for short-term and long-term drug dosimetry |
| 09/24/2008 | CN100420456C Compounded Radix Bupleuri enema preparation and preparing method |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427639 β2-adrenergic receptor agonists |
| 09/23/2008 | US7427638 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/23/2008 | US7427631 especially as inhibitors of MMP12 |
| 09/23/2008 | US7427592 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 09/23/2008 | US7426815 Method and apparatus for loading a container with a product |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |